Fierce Pharma

Bayer has addressed its need for a capital infusion under [...]

The third time is not the charm for Hengrui Pharma [...]

Sanofi has gained FDA approval of its subcutaneous version of [...]

AstraZeneca signed potential billion-dollar licensing deals with CSPC and Sino [...]

After several months of AbbVie leading pharma’s monthly ad spend, [...]

Bleeding disorder patient groups put Sobi, Roche and Novo Nordisk [...]

Aiming to streamline the compensation process for people claiming harm [...]

The FDA took issue with multiple claims describing Vyepti’s efficacy [...]

Novartis is executing more layoffs at its U.S. headquarters in [...]

As Bristol Myers Squibb attempts to convert two accelerated oncology [...]